![](/img/cover-not-exists.png)
PCN66 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINA
W ChenVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71961-1
File:
PDF, 70 KB
english, 2010